| Type |
Details |
Score |
| Allele |
| Name: |
CD22 antigen; targeted mutation 1b, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD22 antigen; targeted mutation 1d, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD22 antigen; endonuclease-mediated mutation 3, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD22 antigen; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD22 antigen; targeted mutation 1c, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD22 antigen; endonuclease-mediated mutation 3, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
C57BL/6JAnu-Cd22/AnuApb |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
C57BL/6J-Cd22 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: C57BL/6J |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129S4/SvJae |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
C57BL/6J-Cd22 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
C57BL/6J-Cd22 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
C57BL/6J-Cd22 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sawzdargo M |
| Year: |
1997 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. |
| Volume: |
239 |
| Issue: |
2 |
| Pages: |
543-7 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, congenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129 * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J) |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 |
| Background: |
C57BL/6N-Cd22/Tcp |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Toda M |
| Year: |
2009 |
| Journal: |
Biochem J |
| Title: |
Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells. |
| Volume: |
417 |
| Issue: |
3 |
| Pages: |
673-83 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Law CL |
| Year: |
1992 |
| Journal: |
FASEB J |
| Title: |
cDNA and genomic organization of the murine B cell associated adhesion protein CD22 |
| Volume: |
6 |
| Issue: |
4 |
| Pages: |
A1131 (Abstr.) |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, transgenic, mutant stock |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 Endou/Endou |
| Background: |
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22<+> |
| Background: |
C57BL/6N-Cd22/Tcp |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 Igh/Igh |
| Background: |
involves: 129 * BALB/c * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22<+> Tg(IghelMD4)4Ccg/? |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
220
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
228
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
291
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22 Igh/Igh<+> |
| Background: |
involves: 129 * BALB/c * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
454
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22<+> Ptpn6/Ptpn6<+> Tg(IghelMD4)4Ccg/? |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22<+> Lyn/Lyn<+> Tg(IghelMD4)4Ccg/? |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd22/Cd22<+> Lyn/Lyn<+> Ptpn6/Ptpn6<+> Tg(IghelMD4)4Ccg/? |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
512
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nishizumi H |
| Year: |
1998 |
| Journal: |
J Exp Med |
| Title: |
A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. |
| Volume: |
187 |
| Issue: |
8 |
| Pages: |
1343-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mattsson N |
| Year: |
2005 |
| Journal: |
Cell Immunol |
| Title: |
Expansion of CD22lo B cells in the spleen of autoimmune-prone flaky skin mice. |
| Volume: |
234 |
| Issue: |
2 |
| Pages: |
124-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hennet T |
| Year: |
1998 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Immune regulation by the ST6Gal sialyltransferase. |
| Volume: |
95 |
| Issue: |
8 |
| Pages: |
4504-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chen WC |
| Year: |
2010 |
| Journal: |
Blood |
| Title: |
In vivo targeting of B-cell lymphoma with glycan ligands of CD22. |
| Volume: |
115 |
| Issue: |
23 |
| Pages: |
4778-86 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ochi H |
| Year: |
2000 |
| Journal: |
Int Immunol |
| Title: |
Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. |
| Volume: |
12 |
| Issue: |
10 |
| Pages: |
1417-23 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu Y |
| Year: |
2005 |
| Journal: |
Immunity |
| Title: |
Lyn tyrosine kinase: accentuating the positive and the negative. |
| Volume: |
22 |
| Issue: |
1 |
| Pages: |
9-18 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sampson M |
| Year: |
2007 |
| Journal: |
Front Biosci |
| Title: |
Src kinases in G-CSF receptor signaling. |
| Volume: |
12 |
|
| Pages: |
1463-74 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
G protein-coupled receptors (GPCRs) constitute a vast protein family that encompasses a wide range of functions (including various autocrine, para-crine and endocrine processes). They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups. We use the term clan to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include the rhodopsin-like GPCRs, the secretin-like GPCRs, the cAMP receptors, the fungal mating pheromone receptors, and the metabotropic glutamate receptor family. The rhodopsin-like GPCRs themselves represent a widespread protein family that includes hormone, neurotransmitter and light receptors, all of which transduce extracellular signals through interaction with guanine nucleotide-binding (G) proteins. Although their activating ligands vary widely in structure and character, the amino acid sequences of the receptors are very similar and are believed to adopt a common structural framework comprising 7 transmembrane (TM) helices [, , ]. A cluster of four intronless GPCR genes, sharing significant sequence similarity with one another, have been identified on human chromosome 19q13.1, downstream from the CD22 gene []. The receptors have been named GPR40, GPR41, GPR42 and GPR43. The GPR42 protein sequence shares more than 98% amino acid identity with GPR41 and is located on a possible polymorphic insert[]. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) PTKs. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR []. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5 []. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules []. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). The SH3 domain of Src kinases contributes to substrate recruitment by binding adaptor proteins/substrates, and regulation of kinase activity through an intramolecular interaction [, ]. |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Gene Segment |
| Type: |
gene_segment |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|